tirzepatide alzheimer A novel therapeutic prospect: a dual-acting for Alzheimer's disease Could diabetes and weight loss

In this part of his Pharmaceutical Executive video interview, Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses the top legal and regulatory concerns for investors considering when financing companies developing or marketing GLP-1 drugs.

What Should You Tell Patients About GLP-1 Use in Pregnancy

In person or by phone, shipped statewide.

At the American Diabetes Associations 2026 Scientific Sessions, CNBCs Angelica Peebles sat down with Lilly CEO Dave Ricks to discuss exactly who could benefit from the high level of weight loss that the companys next-gen weight loss shot delivers

Discuss GLP-1 and GIP treatment options, including Tirzepatide, Semaglutide, Mounjaro, Zepbound, Wegovy, and Ozempic for eligible patients

Take MASLD and OSA, for example